109 related articles for article (PubMed ID: 8800198)
1. Fluorodeoxyuridine-mediated cytotoxicity and radiosensitization require S phase progression.
Lawrence TS; Davis MA; Tang HY; Maybaum J
Int J Radiat Biol; 1996 Sep; 70(3):273-80. PubMed ID: 8800198
[TBL] [Abstract][Full Text] [Related]
2. The effect of activation of wild-type p53 function on fluoropyrimidine-mediated radiosensitization.
Naida JD; Davis MA; Lawrence TS
Int J Radiat Oncol Biol Phys; 1998 Jun; 41(3):675-80. PubMed ID: 9635719
[TBL] [Abstract][Full Text] [Related]
3. The role of cell cycle redistribution in radiosensitization: implications regarding the mechanism of fluorodeoxyuridine radiosensitization.
McGinn CJ; Miller EM; Lindstrom MJ; Kunugi KA; Johnston PG; Kinsella TJ
Int J Radiat Oncol Biol Phys; 1994 Nov; 30(4):851-9. PubMed ID: 7960987
[TBL] [Abstract][Full Text] [Related]
4. Dependence of fluorodeoxyuridine-mediated radiosensitization on S phase progression.
Davis MA; Tang HY; Maybaum J; Lawrence TS
Int J Radiat Biol; 1995 May; 67(5):509-17. PubMed ID: 7775826
[TBL] [Abstract][Full Text] [Related]
5. HPV16-E7 expression causes fluorodeoxyuridine-mediated radiosensitization in SW620 human colon cancer cells.
Axelson MD; Davis MA; Ethier SP; Lawrence TS
Neoplasia; 1999 Jun; 1(2):177-82. PubMed ID: 10933053
[TBL] [Abstract][Full Text] [Related]
6. Fluorodeoxyuridine-induced radiosensitization and inhibition of DNA double strand break repair in human colon cancer cells.
Bruso CE; Shewach DS; Lawrence TS
Int J Radiat Oncol Biol Phys; 1990 Dec; 19(6):1411-7. PubMed ID: 2148170
[TBL] [Abstract][Full Text] [Related]
7. Lack of dependence of 5-fluorodeoxyuridine-mediated radiosensitization on cytotoxicity.
Lawrence TS; Davis MA; Chang EY; Canman CE; Maybaum J; Radany EH
Radiat Res; 1995 Sep; 143(3):281-5. PubMed ID: 7652165
[TBL] [Abstract][Full Text] [Related]
8. Dependence of fluorodeoxyuridine-induced cytotoxicity and megabase DNA fragment formation on S phase progression in HT29 cells.
Tang HY; Weber KL; Lawrence TS; Merchant AK; Maybaum J
Cancer Chemother Pharmacol; 1996; 37(5):486-90. PubMed ID: 8599873
[TBL] [Abstract][Full Text] [Related]
9. Short hairpin RNA suppression of thymidylate synthase produces DNA mismatches and results in excellent radiosensitization.
Flanagan SA; Cooper KS; Mannava S; Nikiforov MA; Shewach DS
Int J Radiat Oncol Biol Phys; 2012 Dec; 84(5):e613-20. PubMed ID: 22867891
[TBL] [Abstract][Full Text] [Related]
10. 5-fluoro-2'-deoxyuridine-induced cdc25A accumulation correlates with premature mitotic entry and clonogenic death in human colon cancer cells.
Parsels LA; Parsels JD; Tai DC; Coughlin DJ; Maybaum J
Cancer Res; 2004 Sep; 64(18):6588-94. PubMed ID: 15374972
[TBL] [Abstract][Full Text] [Related]
11. Biochemical and molecular effects of UCN-01 in combination with 5-fluorodeoxyuridine in A431 human epidermoid cancer cells.
Grem JL; Danenberg KD; Kao V; Danenberg PV; Nguyen D
Anticancer Drugs; 2002 Mar; 13(3):259-70. PubMed ID: 11984070
[TBL] [Abstract][Full Text] [Related]
12. Lack of effect of TP53 status on fluorodeoxyuridine-mediated radiosensitization.
Lawrence TS; Burke R; Davis MA
Radiat Res; 2000 Aug; 154(2):140-4. PubMed ID: 10931684
[TBL] [Abstract][Full Text] [Related]
13. Prevention of fluorodeoxyuridine-induced cytotoxicity and DNA damage in HT29 colon carcinoma cells by conditional expression of wild-type p53 phenotype.
Parsels LA; Zellars RC; Loney TL; Parsels JD; Clarke MF; Merchant AK; Lawrence TS; Maybaum J
Mol Pharmacol; 1997 Oct; 52(4):600-5. PubMed ID: 9380022
[TBL] [Abstract][Full Text] [Related]
14. Fluorodeoxyuridine-mediated modulation of iododeoxyuridine incorporation and radiosensitization in human colon cancer cells in vitro and in vivo.
Lawrence TS; Davis MA; McKeever PE; Maybaum J; Stetson PL; Normolle DP; Ensminger WD
Cancer Res; 1991 Aug; 51(15):3900-5. PubMed ID: 1830239
[TBL] [Abstract][Full Text] [Related]
15. Fluoropyrimidine-mediated radiosensitization depends on cyclin E-dependent kinase activation.
Lawrence TS; Davis MA; Loney TL
Cancer Res; 1996 Jul; 56(14):3203-6. PubMed ID: 8764107
[TBL] [Abstract][Full Text] [Related]
16. Role of the hMLH1 DNA mismatch repair protein in fluoropyrimidine-mediated cell death and cell cycle responses.
Meyers M; Wagner MW; Hwang HS; Kinsella TJ; Boothman DA
Cancer Res; 2001 Jul; 61(13):5193-201. PubMed ID: 11431359
[TBL] [Abstract][Full Text] [Related]
17. Influence of cell cycle phase on radiation-induced cytotoxicity and DNA damage in human colon cancer (HT29) and Chinese hamster ovary cells.
Tang H; Davis MA; Strickfaden SM; Maybaum J; Lawrence TS
Radiat Res; 1994 Apr; 138(1 Suppl):S109-12. PubMed ID: 8146311
[TBL] [Abstract][Full Text] [Related]
18. MLH1 deficiency enhances radiosensitization with 5-fluorodeoxyuridine by increasing DNA mismatches.
Flanagan SA; Krokosky CM; Mannava S; Nikiforov MA; Shewach DS
Mol Pharmacol; 2008 Sep; 74(3):863-71. PubMed ID: 18535288
[TBL] [Abstract][Full Text] [Related]
19. Cell-cycle arrest and p53-independent induction of apoptosis in vitro by the new anticancer drugs 5-FdUrd-P-FdCydOct and dCydPam-P-FdUrd in DU-145 human prostate cancer cells.
Cattaneo-Pangrazzi RM; Schott H; Wunderli-Allenspach H; Rothen-Rutishauser B; Guenthert M; Schwendener RA
J Cancer Res Clin Oncol; 2000 May; 126(5):247-56. PubMed ID: 10815759
[TBL] [Abstract][Full Text] [Related]
20. Cytotoxicity and DNA fragmentation associated with sequential gemcitabine and 5-fluoro-2'-deoxyuridine in HT-29 colon cancer cells.
Ren Q; Kao V; Grem JL
Clin Cancer Res; 1998 Nov; 4(11):2811-8. PubMed ID: 9829747
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
